参考文献/References:
1 Siepmann DB,Siegel A,Lewis PJ.Tl-201 SPECT and 18F-FDG PET for assessment of glioma recurrence versus radiation necrosis.Clin Nucl Med,2005,30(3):199-200.
2 Lichy MP,Bachert P,Henze M,et al.Monitoring individual response to brain-tumour chemotherapy:proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.Neuroradiology.2004,46(2):126-129.
3 Levivier M,Massager N,Wikler D,et al.Modern multimodal neuroimaging for radiosurgery:the example of PET scan integration.Acta Neurochir Suppl,2004,91:1-7.
4 Raman A,Rothrock JF,Liu HG,et al.Differentiation of benign vs.malignant mass in a postirradiation cerebral arteriovenous malformation by 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography.Mol Imaging Biol,2004,6(1):1-6.
5 Lee JK,Liu RS,Shiang HR,et al.Usefulness of semiquantitative 18F-FDG PET in the prediction of brain tumor treatment response to gamma knife radiosurgery.J Comput Assist Tomogr,2003,27(4):525-529.
6 Wong TZ,van der Westhuizen GJ,Coleman RE.PET imaging of brain tumors.Neuroimag Clin N Am,2002,12(4):615-626.
7 Di Chiro G,Oldfield E,Wright DC,et al.Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors:PET and neuropathologic studies.Am J Roentgenol,1988,150(1):189-197.
8 Langleben DD,Segall GM.PET in differentiation of recurrent brain tumor from radiation injury.J Nucl Med,2000,41(11):1861-1867.
9 Kim EE,Chung SK,Haynie TP,et al.Differentiation of residual or recurrent tumors from post-treatment changes with 18F-FDG PET.Radiographics,1999,12(2):269-279.
10 Ricci PE,Karis JP,Heiserman JE,et al.Differentiating recurrent tumor from radiation necrosis:time for re-evaluation of positron emission tomography? Am J Neuroradiol,1998,19(3):407-413
11 Kresnik E,Mikosch P,Gallowitsch HJ,et al.Evaluation of head and neck cancer with 18F-FDG PET:a comparison with conventional methods.EurJ Nucl Med,2001,28(7):816-821
12 Chao ST,Suh JH,Raja S,et al.The sensitivity and specificity of 18F-FDG PET in distinguishing rec urrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.Int J Cancer,2001,96(3):191-197.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]李亚军,白人驹,高硕.PET在前列腺癌中的应用[J].国际放射医学核医学杂志,2006,30(5):283.
LI Ya-jun,BAI Ren-ju,GAO Shuo.The applying of PET imaging in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):283.
[12]王俊起,高硕.PET评价骨转移瘤[J].国际放射医学核医学杂志,2006,30(2):87.
WANG Jun-qi,GAO Shuo.PET in the evaluation of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):87.